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Aims: To develop an objective and easy to complete standardised questionnaire for documentation of
synovial fluid (SF) gross appearance and use it in the assessment of patients presenting to the rheumatology
service with a joint effusion.
Methods: A standardised questionnaire to record the gross appearance of SF was developed. Interobserver
error in recorded observations and direct gross analysis of synovial fluid between four observers was
calculated in a pilot study. In a prospective study over 8 months, SF gross analysis and cell count were
documented in all patients presenting with a joint effusion. Fusch Rosenthal manual counting chamber was
used for calculating SF cell counts.
Results: There was good interobserver agreement on direct gross analysis and between questionnaire
assessors (mean k 0.889). 80 SF samples were collected. Gross analysis was performed in all samples and
cell count in 72. Of the specimens thought to be inflammatory on gross analysis, 31% were found to be non-
inflammatory based on cell count; however, 12 of these patients had an established inflammatory arthritis.
Gross analysis had a sensitivity of 94% and specificity of 58% when used to determine whether SF is
inflammatory or non-inflammatory. The positive and negative predictive values were 0.69 and 0.91
respectively.
Conclusions: SF cell count did not add any information when SF gross analysis suggested a non-inflammatory
process. Gross analysis was better than cell count to determine a potentially septic joint fluid. Further work
needs to be done on the value of SF cell counts if gross analysis suggests the fluid to be inflammatory.
S
ynovial fluid (SF) analysis has been widely recommended
as a crucial aid in the evaluation of patients with arthritis
and joint effusions.1–5 The British Society for
Rheumatology (BSR) and American College of Rheumatology
(ACR) have published guidelines for analysing SF on patients
presenting with joint effusions, which include:
N Gross analysis (viscosity, colour and clarity).
N Cell count.
N Polarised light microscopy (PLM).
N Microscopy and culture.6 7
Gross analysis in particular is a simple bedside test, but is
often poorly performed and documented by medical staff.
A recent postal survey has shown that the use of cell counts is
not widespread and the methods used for performing cell
counts and interpretation of results are not standardised.8
Consequently rheumatologists and orthopaedic surgeons have
low confidence in the results generated.
This study aimed to evaluate these current guidelines on SF
analysis and its relevance to clinical practice.
METHODS
Study design
A prospective study was undertaken in a district general
hospital serving a population of 205 000 between March and
October 2003. All adult patients (.16 years of age) presenting
with a joint effusion were included in the study. This included
patients seen in outpatient clinics or referred from accident &
emergency, medical and other specialties within the hospital.
Three consultant rheumatologists and two middle grades
participated in the study.
Development of standardised questionnaire for
recording SF gross analysis
A standardised questionnaire was developed to analyse and
record the gross appearance of SF according to BSR and ACR
guidelines6 7 (fig 1).
In a pilot study, completion of the questionnaire was tested
on SF samples that were each examined by two independent
observers. One of the observers was blinded to the patient’s
clinical details. Differences in the scoring and the conclusion of
each observer were noted. Interpretation of the questionnaire
results without an opportunity to directly examine the synovial
fluid was also assessed in four independent observers.
Interobserver agreement in this latter task was assessed using
k scores.
Patient demographics
All patients were assessed by any of the five participating
physicians. Patient demographics, known rheumatological diag-
nosis, local examination findings, laboratory results, any joint x
ray results, details of disease modifying antirheumatic drugs
(DMARDs) and previous intra-articular steroid injections were
recorded on standardised forms by the assessing physician.
Gross SF analysis
The questionnaire was used to analyse and record the gross
appearance of SF in the prospective study by the assessing
physician after joint aspiration. A decision was made as to
whether the fluid was non-inflammatory, inflammatory or
potentially septic.
Abbreviations: ACR, American College of Rheumatology; BSR, British
Society for Rheumatology; DMARD, disease modifying antirheumatic drug;
PLM, polarised light microscopy; SF, synovial fluid
1144
www.jclinpath.com
Cell count analysis
SF samples were transported to the laboratory in universal
containers and examined on the same day. Cell counts were
performed using the Fusch Rosenthal chamber via the standard
manual technique by the microbiology technicians. The
following reference ranges were used to differentiate between
the three categories.3 5 9 10
N Non-inflammatory: ,2000 cells/mm3
N Inflammatory: 2000–50 000 cells/mm3
N Potentially septic: .50 000 cells/mm3
PLM and microbiological assays were performed where
clinically indicated. A final diagnosis was then established for
each patient from case sheet review.
Statistical analysis
Kappa and weighed-kappa scores were calculated using
Cohen’s k for pairs of observers. All other statistical analysis
was performed using an SPSS database. Positive and negative
predictive values were calculated for gross SF analysis.
RESULTS
Development of the standardised questionnaire
Twenty-two SF samples were collected for the pilot study. In 10
(45%) of the samples, two observers differed slightly in their
responses to the questionnaire. Despite these minor discrepan-
cies, the conclusion reached by the pair of observers examining
the synovial fluids differed in only 2 (9%) samples. The
description of colour differed in 5 samples, clarity in 4 samples
and viscosity in 2 samples. For colour the difference was mainly
in differentiating between yellow and yellow green (3 samples).
The conclusions of four observers who interpreted the results
of 22 questionnaires without themselves directly assessing the
synovial fluid showed good agreement with a mean k score of
0.889. The four observers only disagreed on the diagnosis of 2
(9%) synovial fluids.
The results from the initial testing of the ‘‘standardised
questionnaire’’ suggest that it can be completed with only
minimal discrepancies occurring between observers.
Furthermore, the final diagnosis following detached interpreta-
tion of the questionnaire shows good agreement across
different observers. It was concluded that in the hands of
physicians with rheumatological training, the questionnaire
can be completed and interpreted reliably.
Patient demographics
Table 1 shows patient demographics. A total of 63 (78%)
patients had a known rheumatological diagnosis: osteoarthritis,
20 (25%); rheumatoid arthritis, 21 (26%); crystal arthritis, 12
(15%); seronegative arthritis, 6 (7.5%); connective tissue
disease, 3 (4%); reactive arthritis, 1 (1%). Eighteen patients
were on DMARDs: hydroxychloroquine (n = 2), methotrexate
(n = 8), sulphasalazine (n = 5), gold (n = 1), leflunomide
(n = 1) and azathioprine (n = 1). None of the patients in this
study were on anti-tumour necrosis factor drugs.
The most common site of aspiration was the knee joint in 73
(91.3%) patients. Other joints involved were knee bursa in 2
(2.5%), shoulder in 2 (2.5%) and ankle in 2 (2.5%) patients.
Aspiration site was not recorded in 1 (1.3%) patient.
Gross analysis
Gross analysis was performed on all 80 SF samples using the
questionnaire. Fluid was categorised as non-inflammatory in 28
(35%), inflammatory in 48 (60%) and potentially septic in 4
(5%) by the physicians.
Cell counts
Cell counts were performed on 72 samples. The remaining 8
samples were too small for cellular analysis. A total of 37 (45%)
were in the non-inflammatory range, 33 (31%) were inflam-
matory and 2 (2.5%) potentially septic. When the cell count
results were compared to gross analysis, fewer samples were
found to be inflammatory (fig 2).
Final diagnosis and synovial fluid cell count analysis
Table 2 illustrates SF cell count and range for final diagnosis.
Crystal analysis
A total of 79 (98.8%) samples were sent for PLM, of which 26
(35%) were positive for crystals.
Calcium pyrophosphate crystals were detected in 16 (21%),
uric acid crystals were present in 8 (10%) and hydroxyapatite
crystals (using Alizarin red stain) in 2 (2.5%).
Gross analysis was inflammatory in 19/26 samples. In the
remaining 7, it was non-inflammatory in 5 (cell count also non-
inflammatory in 2, inflammatory in 1 and not known in 2) and
septic in 2 samples.
Bacteriological analysis
Synovial fluid culture was performed on 79 (98.8%) samples, of
which 4 (5%) were positive. Two samples were positive on both
Gram stain and culture and two were culture positive only. For
the patients with proven septic arthritis, gross analysis was
more sensitive than cell count (fig 2).
Synovial fluid from two patients who subsequently turned
out to have crystal arthritis were initially categorised as
potentially septic on gross analysis.
Inflammatory arthrit is
Thirty-one patients in this study were known to have an
inflammatory joint disease (excluding crystal arthritis). On case
notes review, four of these patients were thought to have the
effusion secondary to osteoarthritis rather than flare up of the
original inflammatory arthritis. Both gross and cell count
analysis indicated non-inflammatory fluid in all four samples.
However, cell count analysis was non-inflammatory in a further
12 samples; five of these patients were on DMARDs (metho-
trexate, n = 3; sulphasalazine, n = 2).
Non-inflammatory arthritis
Twenty patients had a final diagnosis of osteoarthritis. For this
group of patients there was 100% agreement between gross
analysis and cell count findings (fig 2).
Clarity (newsprint test) 
Transparent Translucent Opaque
Viscosity (string test)  
String only String and drops Drops  only
Colour 
Colourless/straw coloured
Yellow/green
White/cream/brown
Blood stained
Haemorrhagic
Figure 1 Standardised questionnaire with tick box system to analyse and
document gross appearance of synovial fluid.
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Cell counts and gross analysis in comparison
Sensitivity of gross analysis in determining whether a fluid was
inflammatory or non-inflammatory was 94% with a specificity
of 58%. The positive predictive value was 0.69 and the negative
predictive value was 0.91.
DISCUSSION
BSR and ACR guidelines recommend that when assessing
patients with a joint effusion gross analysis, PLM, cell counts
and microbiological assays are performed. Other tests such as
mucin clot test, glucose, protein and pH studies have been
shown to be less effective.11
The standardised method of documenting gross analysis of
synovial fluid was found to be helpful, especially when the
synovial fluid specimen was unavailable to view. Where the
fluid was noted to be non-inflammatory on gross analysis, this
was confirmed on cell count; under such circumstances we
would recommend that a cell count is not required. When gross
analysis suggests an inflammatory effusion, correlation with
cell count is poor. There may be several reasons for this.
Firstly, various cell count ranges have been described in the
literature for defining the three major groups (non-inflamma-
tory, inflammatory and septic).The cell count range used by
Freemont et al12 is different to the one used in this study, which
could account for the discrepancy between cell count and gross
analysis diagnoses for inflammatory joint disease and septic
arthritis. We have not looked at the differential SF cell count,
which again has been suggested as helpful.
In our laboratory the reference method for analysing SF cell
count was the use of a cytometer and microscope. The reliability
of this test has been little studied. The available quality control
studies indicate that there is great variation among and within
laboratories in manual counting of white blood cells in SF.13 14 A
recent study15 has shown automated cell counting using the
DIFF channel of Sysmex XE-2100 to produce more precise and
faster results. Repeating this study using automated cell count
methodology might produce different results.
Final diagnosis for each patient was extracted from the case
sheets retrospectively rather than individually reviewing each
patient, which could pose a problem in interpreting the results,
as in usual practice the final diagnosis sometimes changes at
follow-up visits.
Due to the design of the study the physician analysing the
gross analysis of synovial fluid was usually aware of any known
rheumatological diagnosis which could have led to physician
bias in interpreting the gross analysis results, especially in
patients with inflammatory joint disease. In addition, 23% of
patients were on a DMARD, which may have affected the final
SF cell count although none of them had low peripheral blood
white cell counts.
Septic arthritis is a rheumatological emergency and delay in
diagnosis and treatment can lead to irreversible joint damage,
significant morbidity and even mortality.16 The two patients
with proven septic arthritis in this study were both picked up
on gross analysis, and management was initiated even before
Gram stain results were made available. For one patient the cell
count was found to be inflammatory rather than septic,
therefore cell counts alone are unreliable. In a case series of
patients with coexisting gout and septic arthritis, three patients
had cell counts ,6000.17 Cell count results for septic arthritis
were similar.17
Joint effusions present as a diagnostic challenge to physi-
cians and need careful evaluation and interpretation of both
clinical and laboratory findings to make accurate diagnosis,
initiate appropriate management and avoid unnecessary
hospital stay.
The standardised method of documenting gross analysis of
synovial fluid was found to be helpful by both junior and senior
medical staff. We recommend that it is used in daily practice.
This information could be incorporated on to laboratory request
forms and be reported by the laboratory staff at the time of
analysis. This would ensure that this test is performed reliably
and is consistently available to clinicians making treatment
decisions. Where the fluid is non-inflammatory on gross
analysis, a synovial fluid white cell count cannot be recom-
mended. The place of a white cell count in the management of
patients with potential inflammatory arthritis cannot be
determined from this study. However, a white cell count in
the inflammatory range cannot reliably be used to exclude
septic arthritis. Until further work is done to standardise
laboratory cell count methodology, the use of a standardised
gross synovial fluid analysis should be performed in preference
to a laboratory white cell count.
Table 1 Patient demographics
No of patients 80
Age (y), mean (range) 65 (23–97)
No seen in outpatient department (%) 53 (66)
Patients with a known rheumatological diagnosis, no (%) 63 (78)
Patients with known inflammatory arthritis, no (%) 43 (54)
Patients on DMARDs, no (%) 18 (24)
Monoarthritis, no (%) 54(68)
DMARDs, disease modifying antirheumatic drugs.
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Figure 2 Agreement between gross analysis and cell counts for each final
diagnosis.
Table 2 Range of synovial fluid (SF) cell counts and
median for each diagnostic group
Diagnosis n
Cell count range
(cells/mm3)
Median
(cells/mm3)
Osteoarthritis 18 5–960 70
Rheumatoid arthritis flare 17 86–10000 1800
Seronegative arthritis 6 16–7500 1820
Reactive arthritis 4 4500–36800 14850
Crystal arthritis 22 95–70000 3675
Septic arthritis 2 23000–70000 46500
Bursitis 1 4000
Traumatic effusion 2 25–8200 4112
The median SF cell counts for rheumatoid arthritis flare and seronegative
arthritis are in the non-inflammatory cell count range.
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Take-home messages
N Gross analysis is a useful test to differentiate between
inflammatory and non-inflammatory synovial fluid.
N If the synovial fluid is non-inflammatory on gross
analysis, performing a cell count may not add to the
diagnosis.
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